hypertension management

Small Doses: March 2018 Edition
Small Doses: March 2018 EditionEasy-to-swallow news and studies for the busy pharmacist.
New high blood pressure guideline healthcare cost impactFifty percent of Americans have high blood pressure, per new guidelines. Here’s how those guidelines could affect medication utilization and healthcare spending.
Managing patients with hypertension: Tips and strategies to improve the care you provide your hypertensive patientsHypertension needs to be managed quickly and carefully for patients to avoid health problems
Hypertension: Key coding considerationsHere are some key coding considerations when working with patients with hypertension and hypertension related symptoms.
Old guidelines still appropriate for blood-pressure targetsDespite recently published hypertension guidelines for those over the age of 60, it is still appropriate to focus on blood pressure targets set by an older guideline recommended by the American Heart Association and the American College of Cardiology.
Managing hypertension: The knowns and unknownsHypertension is a major cause of morbidity and mortality, and the lifetime risk of developing hypertension is high. It is also widely known that treating hypertension reduces morbidity and mortality even in very old persons, and that an important aspect of blood pressure management is lifestyle modification.
Non-PCP blood pressure screens lead to more diagnoses, better managementExpanding blood pressure screenings to non-primary care settings can help identify more patients with high blood pressure and could contribute to better hypertension control and management, according to a Kaiser Permanente study published in The Journal of Clinical Hypertension.
New guidelines to manage hypertension use evidence-based methodologyHypertension is the most common disease seen among adults in a primary care practice, and is a leading preventable cause for other serious morbidity and mortality. Here are the new guidelines that physicians need to know.
Provider incentives don’t lead to overtreatmentMore research into the way providers and patients respond to incentives will be important to guide healthcare policy.